The National Institute for Health and Care Excellence (NICE) has [...]

Cereno Scientific has reported initial long-term safety findings from a [...]

Chiesi Global Rare Diseases has received a positive CHMP opinion [...]

Liver-metabolic disease is linked to increased heart failure risk in [...]

As Rare Disease Day 2026 shines a spotlight on patients [...]

Circio Holding ASA, a biotechnology company developing circular RNA-based gene [...]

CellProthera has acquired full rights to the transendocardial catheter originally [...]

Cereno Scientific has completed the last patient’s last visit in [...]

Milestone Pharmaceuticals has announced the commercial availability of CARDAMYST (etripamil) [...]